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Abstract
Background: CRISPR and CRISPR-flanking genomic regions are important for molecular epidemiology of Mycobacterium
tuberculosis complex (MTBC) strains, and potentially for adaptive immunity to phage and plasmid DNA, and endogenous
roles in the bacterium. Genotyping in the Israel National Mycobacterium Reference Center Tel-Aviv of over 1500 MTBC
strains from 2008–2013 showed three strains with validated negative 43-spacer spoligotypes, that is, with putatively
deleted direct repeat regions (deleted-DR/CRISPR regions). Two isolates of each of three negative spoligotype MTBC
(a total of 6 isolates) were subjected to Next Generation Sequencing (NGS). As positive controls, NGS was performed
for three intact-DR isolates belonging to T3_Eth, the largest multiple-drug-resistant (MDR)-containing African-origin
cluster in Israel. Other controls consisted of NGS reads and complete whole genome sequences from GenBank for
20 intact-DR MTBC and for 1 deleted-DR MTBC strain recognized as CAS by its defining RD deletion.
Results: NGS reads from negative spoligotype MTBC mapped to reference H37Rv NC_000962.3 suggested that the
DR/CRISPR regions were completely deleted except for retention of the middle IS6110 mobile element. Clonally
specific deletion of CRISPR-flanking genes also was observed, including deletion of at least cas2 and cas1 genes.
Genomic RD deletions defined lineages corresponding to the major spoligotype families Beijing, EAI, and Haarlem,
consistent with 24 loci MIRU-VNTR profiles. Analysis of NGS reads, and analysis of contigs obtained by manual PCR
confirmed that all 43 gold standard DR/CRISPR spacers were missing in the deleted-DR genomes.
Conclusions: Although many negative spoligotype strains are recorded as spoligotype-international-type (SIT)
2669 in the SITVIT international database, this is the first time to our knowledge that it has been shown that
negative spoligotype strains are found in at least 4 different 24 loci MIRU-VNTR and RD deletion families. We
report for the first time negative spoligotype-associated total loss of CRISPR region spacers and repeats, with
accompanying clonally specific loss of flanking genes, including at least CRISPR-associated genes cas2 and cas1.
Since cas1 deleted E.coli shows increased sensitivity to DNA damage and impaired chromosomal segregation,
we discussed the possibility of a similar phenotype in the deleted-DR strains and Beijing family strains as both
lack the cas1 gene.
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Background
The National Public Health Laboratory Tel Aviv, National
Mycobacterium Reference Center routinely genotypes all
new culture-positive tuberculosis cases in Israel [1] with
43 spacers reverse line blot spacer oligonucleotide typing
(spoligotyping) [2–4], and 24 loci mycobacterial inter-
spersed repeat units – variable number tandem repeats
(MIRU-VNTR) typing [5] using multiplex PCR and capil-
lary electrophoresis [6, 7]. The results are stored in Excel
(Microsoft), BioNumerics (Applied Maths, Belgium), and
WHOnet databases. From 2008–2013, over 1500 strains
were genotyped and tested for drug sensitivity to first line,
and when necessary, second line drugs. Six drug-sensitive
isolates from three different patients A, B, and C (two
isolates per patient) yielded negative spoligotyping results
and three different 24 loci MIRU-VNTR profiles respect-
ively (Additional file 1: Table S1).
Variation in the structure of CRISPR and CRISPR-
flanking regions of these negative spoligotype MTBC
isolates was observed when NGS reads were mapped on
reference whole genome sequence H37Rv NC_000962.3.
This yielded visualization of coverage (Fig. 1). After
substitution of manual-PCR-derived DR-spanning se-
quences for the corresponding map-derived regions,
further details of structural variation were revealed by
alignments of annotated subsequences containing CRISPR
plus CRISPR-flanking regions to the annotated reference
H37Rv sequence (Fig. 2).
In addition to the 6 drug-sensitive deleted-DR isolates,
two drug sensitive and 1 multiple-drug-resistant (MDR)
intact-DR strains from T3_Eth (SIT 149), our largest
African-origin MDR-containing cluster, were analyzed
by NGS (Table 1, Additional file 1: Table S1, Additional
file 2: List S1). These provided positive controls for the
sensitivity of our methods to correctly characterize
from NGS data, the CRISPR-Cas regions of intact-DR
MTBC, especially with respect to the presence or ab-
sence of CRISPR spacers.
Complete loss of all Direct Repeat region (DR) repeats
and spacers, negative spoligotyping results, and loss of
genes in flanking regions has been reported previously
for MTBC with negative spoligotypes [8, 9] identical to
those currently assigned to SIT 2669 [10] and for other
bacteria [11], however, the molecular structures of the
CRISPR regions (the newer name for DR) and flanking
CRISPR-associated (Cas) regions [12] were not reported,
except for a comparison to the homologous genomic
region in non-tuberculous mycobacteria (NTM) [13].
The evidence reported herein clearly showed that the
deleted-DR and accompanying deleted CRISPR-flanking
Fig 1 Location and coverage of H37Rv-mapped NGS-reads of negative-spoligotype strains A, B, C and intact-DR T3_Eth
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genes of the MTBC described in this study were not an
instance of the ORFs absent in NTM species (Fig. 2).
Also, this study is the first known to us to employ iden-
tification of Region of Difference (RD) deletions in order
to assign negative spoligotype MTBC to their corre-
sponding major spoligotype families.
The MTBC RD deletions are genomic long sequence
polymorphisms (LSPs) [14, 15] which were detected
in this study by aligning Mycobacterium tuberculosis
complete genome sequences (obtained from public on-
line databases or derived from NGS reads mapped on
the H37Rv genome, Table 1) with the MTBC reference
strain H37Rv complete genome sequence [16]. The
MTBC RD deletions, and also an extensive set of single
nucleotide polymorphisms (SNPs), have been shown by
Coll et al. [17] in an on-line available application for ana-
lysis of NGS reads, to have phylogenetic behavior that
corresponds well with the phylogenetic distribution ob-
tained by analysis of 43-spacer spoligotypes. 43-spacer
spoligotypes have been assigned type numbers and fam-
ily names [10, 18]. The 43-spacer spoligotypes are more
informative than the RD types and SNP types, thus any
given specific 43-spacer spoligotype cannot be inferred
from an RD type or SNP type, but the spoligotype family
can be inferred from RD or SNP information, and in
addition some sub-lineage information can be obtained
from the SNP type [17]. Therefore, when one encounters
a negative spoligotype by conventional screening for the
43 CRISPR spacers, if NGS sequencing can be performed
for the deleted-DR strain, two convenient ways exist to
determine the spoligotype family: 1) map the NGS
reads to reference H37Rv, align the constructed MTBC
sequence with the H37Rv sequence, and search for the
relevant RD deletions, and 2) submit the NGS reads to the
Coll et al. [17] site for analysis of RD deletions and SNPs.
The RD data shown in Table 1 suggested that a third way
could be developed which would not require sequencing
for NGS reads: a possible multiplex PCR probe for rele-
vant RD deletions, which could be analyzed by fragment
analysis as in MIRU-VNTR typing, or by real time PCR.
Various methods have been proposed for spoligotyping
from NGS reads [19–22], but all involve detection of
CRISPR spacers and thus would only yield negative results
with our deleted-DR negative spoligotype strains.
A combination of the PCR-based methods 43 spacer
spoligotyping and 24 loci MIRU-VNTR typing has re-
placed RFLP-typing as the MTBC genotyping screen of
choice, due to the speed and convenience of the PCR-
based methods, genotype discrimination as good as or
better than that for RFLP-typing, and the ability to store
the PCR-based results in easily manipulated digital for-
mat [5]. On a population level, screening for spoligotype
Fig 2 Structure and variation of CRISPR and CRISPR-flanking regions in deleted-DR and intact-DR MTBC
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family provides insight into the bio-geographic burden of
TB in the world and for any particular country [1, 10, 18].
Thus it is useful to be able to determine the spoligo-
type family for a strain that has a negative spoligotype
by conventional screening. While in general the more
informative 24 loci MIRU-VNTR type will still
phylogenetic-wise segregate according to its comple-
mentary spoligotype [5], for certain MIRU-VNTR
Table 1 Characteristics of NGS sequenced deleted-DR sample strains A, B, C and intact-DR T3_Eth, and whole genome sequences
obtained on-line or assembled from on-line read sets#






mutation in regions of difference (RD)
mutT4 T2 ogt 105 207 181 150 142 182 239 750
Beijing
BT1, CP002883 000000000003771 1,Beijing TDRa inv 48 58 12 del del del wt wt wt wt wt
BT2, CP002882 000000000003771 1,Beijing TDRa inv 48 58 12 del del del wt wt wt wt wt
CCDC5079, CP001641 000000000003771 1,Beijing DSb inv 48 58 12 del del del wt wt wt wt wt
CCDC5180, NC_017522.1 000000000003771 1,Beijing MDRb inv 48 58 12 del del del wt wt wt wt wt
HKBS1, CP002871.1 000000000003771 1,Beijing DSa inv 48 58 12 del del del wt wt wt wt wt
Beijing [−like], CP010873.1 000000000003731 190,Beijing MDRc inv 48 58 12 del del del wt wt wt wt wt
SRR671761 000000000003771 1,Beijing ?d unk 48 58 12 del del del del wt wt wt wt
SRR671726 000000000003770 1,Beijing XDRd unk 48 58 12 del del del wt wt wt wt wt
B_1042-11 000000000000000 nS,Beijing DSe wt 48 58 12 del ext del wt wt wt wt wt
B_1114-11 000000000000000 nS,Beijing DSe wt 48 58 12 del ext del wt wt wt wt wt
Proto-Beijing
SRR1710057 777777777777731 246, U panSd unk wt wt wt ext wt wt wt wt wt wt wt
SRR1710058 777777777775331 nS panSd unk wt wt wt ext wt wt wt wt wt wt wt
SRR1710061 777777777777771 523, U panSd unk wt wt wt ext wt wt wt wt wt wt wt
Non-Beijing
ERR176616 777777607060771 nS MDRd unk wt wt wt wt wt wt wt wt wt wt wt
ERR190365 000037777403471 nS,EAI DRd unk wt wt wt wt wt wt wt wt wt del wt
ERR212132 776337777760771 71, S panSd unk wt wt wt wt wt wt wt wt wt wt wt
SRR671740 777777777760771 53, T1 XDRd unk wt wt wt wt wt wt wt wt wt wt wt
SRR1188186 000000000000000 nS,CAS panSd unk wt wt wt wt new wt wt wt wt wt del
A_0389-12 000000000000000 nS,Haarlem DSe wt wt wt 15 wt new wt wt wt del wt wt
A_1124-11 000000000000000 nS,Haarlem DSe wt wt wt 15 wt new wt wt wt del wt wt
C_0253-12 000000000000000 nS,EAI DSe inv wt wt wt wt new wt wt wt wt del wt
C_0309-12 000000000000000 nS,EAI DSe inv wt wt wt wt new wt wt wt wt del wt
T3_Eth_0140-11 777000377760771 149,T3_Eth DSe unk wt wt wt wt wt wt wt wt wt wt wt
T3_Eth_0192-11 777000377760771 149,T3_Eth MDRe unk wt wt wt wt wt wt wt wt wt wt wt
T3_Eth_0525-11 777000377760771 149,T3_Eth DSe unk wt wt wt wt wt wt wt wt wt wt wt
BCG1173P2, NC_008769.1 676773777777600 482,BCG DRf wt wt wt wt wt wt wt wt del wt wt wt
CDC1551, AE000516.2 700076757760771 549,X3 DSg wt wt wt wt wt wt wt wt wt wt wt wt
CTRI-2, CP002992 777777607760771 42,LAM9 DSg wt wt wt wt wt wt wt wt wt wt wt wt
F11, CP000717.1 776177607760771 33,LAM3 DSg wt wt wt wt wt wt wt wt wt wt wt wt
Haarlem, CP001664 775777774020751 H1-like DRg wt wt wt 15 wt wt wt wt wt del wt wt
#ID, sample, read set or NCBI accession number; octal, from spoligosome17, SIT, spoligotype international type and associated family; nS, no SIT; Drug Res,
resistant to drug, I-isoniazide, R-rifampicin, E- ethanbutol, S-streptomycin, P-pyrazinamide, DS (drug sensitive): none, DR (drug resistant): at least one but not I&R
together: MDR (multiple drug resistant): at least I&R, XDR (extensively drug resistant): at least MDR plus defined 2nd line drugs consisting of at least 1 quinolone
and at least one of the injectable drugs kanamycin, capreomycin or amikacin, TDR (totally drug resistant): resistant to all 1st and 2nd line drugs. a-g: Additional
file 2: List S1 – sources of drug sensitivity data; wt, identical to reference genome H37Rv NC_000962.3; CRISPR IS6110, orientation of the IS6110 mobile element
found in the direct repeat region, wt: same orientation as in H37Rv, inv: inverted, unk: unknown; mutation in mutT4 (Rv3908), codon 48: Arg CGG GGG Gly; mutation
in mutT2 (Rv1160), codon 58: Gly GGA CGA Arg; mutation in ogt (Rv1316c), silent codon 12: Gly CCC TCC Gly, missense codon 15: Thr GGT GCT Ser (note: ogt gene is
in inverse orientation); regions of difference RD, 105: proto and all modern Beijing, 207: LSP in CRISPR region defining modern Beijing – includes cas gene deletions,
181-150-142: polymorphic LSPs for Beijing, 182: marker for Haarlem, 239: marker for EAI, 750: marker for CAS
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profiles the miru-spoligo correlation may be difficult to
establish. A published example of this [7] showed that
the MIRU-VNTR profiles in spoligotype families CAS
and Beijing can sometimes be difficult to distinguish.
In another case, very similar MIRU-VNTR profiles
were found in both the T and LAM spoligotype families
(unpublished). In these cases it was not only useful, but
indeed necessary, to determine at least the spoligotype
family. On a clinical level, the combination of spoligo-
type and MIRU-VNTR type complements and guides
classical epidemiological investigation to clarify ques-
tions of transmission between individuals, transmission
chains among larger groups of individuals, questions
about whether a recurrence of TB is due to reactivation
or reinfection, and resolution of questions arising when
a lab provides a positive TB report that is inconsistent
with the physician's observation – that is- the possibil-
ity of a false positive due to lab contamination. Often
24 loci MIRU-VNTR alone supplementing classical
epidemiology is enough to resolve these issues. Never-
theless, if the strains involved have negative spoligo-
types on conventional screening, knowledge of at least
the spoligotype family (and even better, the sub-lineage
from SNP data) can help validate the results concluded
from classical epidemiology supplemented with MIRU-
VNTR typing. Finally, there are often gaps in epi-
demiological knowledge when trying to establish trans-
mission chains among larger groups of individuals.
These knowledge gaps can be exacerbated by subtle
polymorphisms (1 locus, 1 copy number) in MIRU-
VNTR profile, where knowing only the spoligotype
family will not be enough to firmly establish the trans-
mission chain. Therefore, when confronted with nega-
tive spoligotypes in large putative transmission chains,
it seems reasonable to recommend that all the strains
should be processed for NGS reads. Then the NGS
reads for the negative spoligotype strains should be
used for spoligotype family determination [17], and
subsequently for SNP clonality-check comparisons
among the strains to delineate the outbreak [23, 24].
Mycobacterium tuberculosis complex (MTBC) bacteria
possess a Type III-A CRISPR-Cas system structurally
homologous to Type III-A of other genera [12]. Active
Type III-A systems provide adaptive immunity to bac-
teriophage and plasmids [12, 25, 26], and perform en-
dogenous roles, for example, endogenous DNA repair
via Cas1 endonuclease [27].
In MTBC the CRISPR region is also known as the
direct repeat region (DR). Polymorphism in the number
and type of 43 spacers in the DR/CRISPR region of any
given MTBC strain, has been and continues to be exten-
sively used for molecular epidemiology of MTBC, espe-
cially for overviews of phylogenetic and bio-geographical
distributions of clades [2, 4, 10, 18]. Fourty three-spacer-
SPO-plus-24-loci-MIRU genotyping provides molecular
epidemiology at the resolution of clonal transmission
[5], with the exception of certain instances, for example,
of convergent evolution [28].
The functional activity of the MTBC CRISPR-Cas sys-
tem remains to be investigated, but the highly conserved
sequence and order of the 43 CRISPR/DR region spacers
[3] which is the basis for the epidemiological and phylo-
genetic usefulness of polymorphism on spacer oligo-
nucleotide typing (spoligotyping), has been interpreted
to imply at least partial inactivity of the MTBC CRISPR-
Cas system [29]. This interpretation presumes that the
insertion of new spacers in the CRISPR/DR region is
one of the fundamentals of, and evidence for, adaptive
immunity, and thus lack of evidence for insertion of new
spacers in MTBC implies at least partial inactivation of
the CRISPR-Cas adaptive immune system in MTBC.
The MTBC Type III-A CRISPR-Cas system [12] is de-
fined by the presence of cas10/csm1 and csm accessory
genes, and is predicted to be in some manner active on
the basis of the presence of intact cas1 and cas2 genes.
In addition, some sort of activity even if only in en-
dogenous roles, can be predicted from GenBank annota-
tion that informs of mass spectroscopy support [30] for
the existence of most of the cas gene products, including
Cas1in the reference MTBC strain H37Rv. The lineage-
defining RD 207 deletion [14, 31] of the super-spreader
MDR-containing Beijing family includes complete dele-
tion of cas1 and cas2 genes (Fig. 2), so possession of a
fully active Type III-A CRISPR-Cas system is not a pre-
requisite for a successful (with respect to pathogenicity,
transmissibility, and adaptability) MTBC lineage. Interest-
ingly, the complete loss of CRISPR spacers in E. coli gave
the same DNA-repair deficient phenotype as deletion of
the E. coli cas1 (ygbT) gene [27]. Using M. smegmatis as a
model for MTBC [32], Cas2 [33] by itself was shown to
be deleterious to Mycobacterium survival, thus it may be
significant that deletion of cas1 was always accompanied
by deletion of at least cas2.
In summary, the results showed that complete deletion
of DR region repeats and spacers in negative-spoligotype
MTBC was accompanied by clonal-specific loss of flank-
ing genes, always accompanied by complete deletion of
cas2, complete deletion of putative (functional activity
still unknown in MTBC) DNA-repair gene cas1, and re-
tention of the middle IS6110 mobile element. For the
first time it was shown that negative spoligotype MTBC
nevertheless could be assigned to major spoligotype
families by identification of NGS-revealed corresponding
lineage-defining RD deletions. Since there was only 1
deleted-DR strain-type (based on at most two isolates)
per RD-defined family, there was not enough informa-
tion to decide if the loss of cas genes was solely clonally
specific, or perhaps had lineage-defining features.
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Methods
Growth of Mycobacterium tuberculosis strains, and drug
sensitivity tests
All approximately 1500 new culture-positive MTBC strains
collected during 2008–2013 were analyzed. Cultures were
grown and identified as MTBC as previously described
[7]. Drug sensitivity tests were performed as previously
described [7].
Extraction of MTBC DNA
Preparations of RFLP-grade MTBC DNA for NGS se-
quencing, and of “crude” sonicated, heated extract for
genotyping, were done as previously described [7].
Genotyping of MTBC DNA
Routine genotyping of MTBC DNA by 43 spacer spoli-
gotyping (reverse line blot kit, Omicum, India) and 24
loci MIRU-VNTR typing (in house multiplex PCR and
amplicon-sizing by capillary electrophoresis) were done
as previously described [6, 7]. BCGP2 was the generous
gift of Professor Hillel Bercovier, Hebrew University of
Jerusalem. European Communicable Disease Center Profi-
ciency Test (ECDCPT) samples 21 and 25, and ECDCPT
H37Rv control DNA were obtained originally as profi-
ciency test materials [34]. Genotyping results were stored
in an Excel (Microsoft) database, a BioNumerics ver7.6
database, and a WHONET database.
NGS Assay and bioinformatics analyses at the Scripps
Research Institute, including 1) coverage-curves illustrating
deletion of CRISPR/DR-Cas regions present in the template
reference H37Rv chromosome sequence, and 2)
determination of spoligotypes from NGS reads
RFLP-grade DNA samples (micrograms of highly con-
centrated, highly purified, high quality DNA) were sent
to Mgr. Steven Robert Head and Mgr. Lana Schaffer of
the Scripps Research Institute in San Diego, California
USA for NGS and draft bioinformatics analysis.
One microgram of each sample was sheared on the
Covaris S2. Each sample was then end repaired, a-tailed
and adapter ligated. The samples were cleaned with
Agencourt beads and treated with 6 cycles of PCR.
After PCR the samples were cleaned using Zymo 25
columns and loaded on a 2% agarose gel. The gel was
cut from 400–700 bp and cleaned again with the
Zymo25 column.
The samples were sequenced on an Illumina Miseq
system as paired-end reads each with length 300 bp. The
alignment was performed using Novoalign v3.00.05
(http://www.novocraft.com) without soft clipping to allow
reads which cross the ends of the reference sequence as
would be the case of a circular genome. The Mycobacter-
ium tuberculosis reference sequence used for the
alignment was MTB-H37Rv-asm19595v2 and for repeat
sequences not in the mapped-to-H37Rv MTBC sequence
was Mycobacterium bovis AF2122/97. The reads were pre-
processed by trimming adaptor sequences (GATCGGAA-
GAGCACACGTCTG), trimming by base call quality
scores lower than 26, removing unmapped reads and du-
plicate reads, and removal of reads with mapping quality
score less than one. Repeat sequence coordinates and se-
quences were taken from the Jansen paper [35].
For coverage curves illustrating deletion of CRISPR-DR-
Cas regions that were present in the template H37Rv
chromosome sequence, the aligned bam files were con-
verted to wig files using bamtools, bedtools, and ucsc-
tools. The wig files were imported into UCSC Microbial
Genome Viewer (http://microbes.ucsc.edu).
Recovery of spoligotypes from NGS data was accom-
plished as follows. A bed file was created using the co-
ordinates of the 43 DR repeat units. This bedfile and
the aligned bam files were used with “samtools bedcov”
tool to output number of counts for each repeat unit.
In order to produce a binary table matching the spoli-
gotyping regions with less than 500 counts were con-
sidered absent.
Bioinformatics at the National Public Health Laboratory
Tel Aviv
Analyses of our NGS raw data were accomplished by
use of BioNumerics version 7.5 and 7.6 (Applied Maths,
Belgium) import and processing of 1) cleaned paired-
end and single-end fastq reads received from Scripps, 2)
reads formatted as sra (in fastq format) and fastq files
downloaded from NCBI or other sources, and 3) fastq
or EMBO/GB format reference whole chromosome
sequences or contributed chromosome sequences from
NCBI or other sources. For visualization of the mo-
lecular details of the CRISPR-DR and flanking regions
(including Cas genes), reads were resequenced/mapped
onto reference H37Rv NC_000962.3 using default
parameters with the following changes: accept paired-
end reads, minimum coverage 10, minimum sequence
length before considered for contig 500 nt. The “cover-
age” was examined as percentage of the H37Rv genome
matched, and as the number of reads contributing to
each base pair assignment.
The mapped chromosomes were annotated with H37Rv
GenBank and BioNumerics-predicted (based on possible
reading frames) features and matrix compared and aligned
in chromosome comparison mode using default parame-
ters. For decisions about reading frames and codon assign-
ments, reference H37Rv NC_000962.3 annotated only
with GenBank annotation was included in comparisons.
Default parameters were: I. Comparison Project type:
full sequence based; Matrix: matrix; self-comparison of
sequences; direct sequence orientation; inverted se-
quence orientation; Seed extension DNA seed: minimum
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15 matches in window size of 25 bases; Amino acid seed:
minimum 6 matches in window size of 10 amino acids;
Stretch extension Minimum 15 matches in window size
of 30 bases; Minimal stretch length: 50; II. Seeds Seed
database: seed 11111, type: DNA, length:5; Seeds used
in project: seed 11111, type: Transl, length:5, and III.
Alignment settings template entry: usually the GB plus
BN annotated reference H37Rv; stretch import mini-
mum length: 0; Minimum identity: 0; Stretch mapping
Open gap penalty: 10; Extend gap penalty 10; do NOT
allow repetition of mapped stretches (box should NOT
be checked); full alignment of stretch ends: checked; Full
alignment settings: open gap penalty (%): 100; extend
gap penalty (1%): 0; use fast algoritm: checked; K-tuple
size:2; No. of diagonals (1–200): 99. This generated a
schematic suitable for visualization of deletions, while
choosing “show text view” while in alignment sub-mode
in the comparison mode allowed visualization of single
nucleotide polymorphisms (SNPs). An important point
is that any given set of parameters has its own strengths
and limitations. The default parameters of BioNumerics
7.5 and 7.6 Chromosome Comparison did not detect
inverse IS6110 in the CRISPR-Cas region (it appeared
as a deletion), nor were they suitable for comparison of
shorter sequences (for example, sequences of 44 thou-
sand nucleotides/nt or less).
The region containing the CRISPR-Cas sequence plus
flanking regions was cut out (maximum approximately
44 thousand nt), annotated and used for further compar-
isons in the alignment window when high similarity was
expected, or in the chromosome comparison mode and
alignment sub-mode with appropriate parameters when
some dissimilarity was expected.
The appropriate parameters for comparison of shorter
sequences in the Chromosome Comparison mode were
(only parameters differing from the default parameters
detailed above are given): I. Comparison Seed extension:
DNA seed: minimum 6 matches in window size of 15
bases; Amino acid seed: minimum two matches in win-
dow size of 5 amino acids; Stretch extension: minimum
6 matches in window size of 10 bases; Minimal stretch
length: 12; II. Seeds seed database: seed: 111; type: DNA;
length: 3; Seeds used in project: seed: 111; type: DNA;
length: 3; III. Alignment settings: Full alignment settings:
open gap penalty (%): 0; No. of diagonals (1–200): 30.
Other parameter sets can be better for other uses, and
must be determined empirically.
In order to obtain contig-corrected sequences for the
six approximately 44 Kbp CRISPR plus CRISPR-flanking
subsequences of the deleted-CRISPR strains from patients
A, B, and C, the NGS-obtained H37Rv-mapped subse-
quences containing the CRISPR-spacers regions (the DR
regions) were excised from the assembled mapped whole
genome sequence at predetermined flanking genes on
each side, and replaced with sequences of PCR validated
contigs spanning the CRISPR-spacers-DR region, that is,
with 5’ and 3’ ends of the contigs overlapping the con-
served CRISPR-flanking genes (Fig. 2) characteristic for
each deleted-DR strain. These “DRplus” sequences cor-
rected for the appropriate contigs are found in Additional
file 3: Sequences S1–S6. The CRISPR-flanking genes and
their locations are listed in Additional file 4: Table S2.
The PCR validated contigs were constructed using
primers inferred from the NGS data from mapped to
H37Rv, and de novo, sequences (de novo sequences ob-
tained using the open-source short-read assembly pro-
gram “Ray” employed by the Power Assembler tool of
Applied Mathematics software BioNumerics version 7.5
and version 7.6) according to which regions could be ex-
pected to be “conserved” in the CRISPR-spacers region
itself (that is, the IS6110 mobile element), and in the im-
mediately adjacent CRISPR-flanking regions characteristic
for each deleted-DR strain. PCR and agarose gel electro-
phoresis were performed as previously described [7] and
the PCR product purified on QIAQUICK (QIAGEN) col-
umns. The purified PCR product was sent for forward
and reverse sequencing to a commercial sequencing facil-
ity (HyLabs, Rehovot), and the sequences from the ab1
sequencing files were trimmed and used to construct con-
tigs spanning the CRISPR-spacers region (BioNumerics
version 7.5). Validation of sequence trimming and align-
ment for contig construction was done in parallel using a
different bioinformatics tool (Clone Manager 9).
The H37Rv NC_000962.3 whole genome sequence
locations, corresponding to the DR plus flanking regions
(sequences named DRplus) of the mapped deleted-DR
strains A, B, and C, were used for alignments for primer
construction (Additional file 4: Table S2). The major
primers used for manual PCR were as shown in Additional
file 5: Table S3.
Recovery of spoligotypes from NGS reads, or from
downloaded reference or contributed chromosomes, was
accomplished by constructing a new BioNumerics version
7.5 (now 7.6) application, manuscript in preparation. In
addition, the sequences for the DR region-spanning
contigs for deleted-DR strains A, B, and C were exam-
ined by NCBI BLAST for sequences corresponding to
spacer sequences.
Drug sensitivity and lineage information for down-
loaded reads was obtained either from the literature
(Table 1, Additional file 2: List S1) [14, 15] or by uploading
the reads to TB Profiler [36] which reported back the drug
sensitivities for first and second line drugs, and projected
lineages. RD deletion confirmation of lineages (Table 1)
was obtained from BioNumerics Chromosome Com-
parison alignments of complete genome sequences
(downloaded whole, or derived from assembly of H37Rv-
mapped-reads) to the reference H37Rv sequence.
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Results and Discussion
Variation in the CRISPR and CRISPR-flanking regions:
clonal specific deletion of CRISPR-flanking regions in
deleted-DR strains – including deletion of at least cas1
and cas2, and retention of the IS6110 mobile element in
deleted-DR strains
In Fig. 1, coverage of the homologous reference H37Rv
sequences was approximately 150 reads for each isolate,
with the negative spoligotype isolates A, B, and C showing
wide gaps to the left and right of the middle sequence.
The middle read-coverage length was suggestive of that of
an IS6110 mobile element. The coverage of the template
H37Rv genome (NC_000962.3) (4411532 bp) ranged from
97.4 to 99.1% for the deleted-CRISPR-spacers-Cas strains
A, B, and C, and 98.3 to 99.2% for the T3_Eth strains.
Variations in the CRISPR and CRISPR-flanking regions
of negative spoligotype (Additional file 1: Table S1)
MTBC isolates from patients A, B, and C were observed
in the visualization of NGS reads mapped on reference
H37Rv NC_000962.3 (Fig. 1) and annotated alignments
of DRplus (DR plus flanking sequences) subsequences to
the DRplus reference H37Rv subsequence (Fig. 2). For
comparison, intact-DR results from three NGS-sequenced
T3_Eth were shown.
DRplus subsequences from isolates A, B, C, and isolate
SRR1188186 which was assembled from downloaded
reads, were aligned to reference template H37Rv sub-
sequence (Fig. 2, Additional file 4: Table S2). A, B, and
C – specific (that is, clonally specific) deletions of
CRISPR-flanking genes were observed, including dele-
tions of cas genes to the right of the retained mid
IS6110. All 4 deleted-DR strains, retained their mid
IS6110 mobile element, and deleted at least cas2 and
cas1 (Fig. 2, Additional file 4: Table S2).
The deleted-DR B isolates showed a right-side deletion
of the same size and location as that shown in Beijing-
family strains (Fig. 2). Subsequent RD deletion identifica-
tion of deleted-DR B isolates as Beijing (Table 1), sug-
gested that the B deletion may be an extension of the
Beijing lineage-defining RD207 deletion. This was fur-
ther suggested by the fact that the deleted-DR B isolates
shared the Beijing-specific mutator phenotype SNPs
mutT4|T2|ogt [37] (Table 1). Thus we propose to name
the deletion seen in the deleted-DR B isolates as “extended
RD207” in accordance with the terminology adopted by
Luo et al. [31] for the RD105 deletion in proto-Beijing: ex-
tended RD105 (Table 1). It was interesting, but of as yet
unproven important significance as discussed below, that
in contrast to the inverse orientation of the IS6110 mobile
element in the DR region of many if not all validated
Beijing-family sequences (Additional file 6, Figure S1) the
orientation of IS6110 in the Beijing deleted-DR B isolates
was wild type, that is, the same as for reference template
H37Rv (Additional file 6: Figure S1, Table 1).
Validation of retention of mid-IS6110 mobile element, and
of loss of varying amounts of genomic regions flanking the
deleted CRISPR/DR regions of isolates A, B, and C
In order to validate retention of IS6110, and clonally
specific loss of flanking genomic sequences in deleted-
DR isolates A, B, and C, primers were chosen from con-
served flanking genes and the mid IS6110, and used to
generate amplicons by manual PCR which were assem-
bled into contigs for a DR-spanning sequence for each
isolate A, B, and C. These validated DR-spanning se-
quences were substituted into the DRplus sequences of
H37Rv-mapped isolates A, B, and C, resulting in a “cor-
rected’ DRplus sequence for each isolate A, B, and C
(Additional file 3: Sequences S1–6). Alignment of the
corrected DRplus sequences to template H37Rv (Fig. 2)
confirmed that mid-IS6110 was retained in each deleted-
DR isolate A, B, and C. It was interesting that the orien-
tation of this IS6110 of each Beijing deleted-DR isolate B
was wild type with respect to H37Rv, and inverse with
respect to the orientation of IS6110 observed in refer-
ence whole genome Beijing sequences (Additional file 6:
Figure S1, Table 1). Alignment of the manual PCR
corrected DR plus flanking sequences to template
H37Rv (Fig. 2) also confirmed the clonally specific loss
of CRISPR-flanking regions, as shown in Fig. 2 and
detailed in Additional file 4: Table S2. Each deleted-DR
isolate A, B, and C showed deletion of at least cas2 and
cas1 from among the cas genes (Fig. 2, Table 2, Additional
file 4: Table S2).
The absence of mutations in csm3, csm2, and cas6
(Table 2) could mean that those genes cannot tolerate
mutations due to the importance of their sequence, or
transcription or translation products. However, mutations
could appear if a larger set of strains were examined, a
possibility suggested by the recent report that the cas6
gene is dispensable in Type III CRISPR-cas systems [12].
Did the retained IS6110 mobile element have a role in
generating the CRISPR and flanking-sequences deletions
observed in the deleted-DR strains?
The mobile element IS6110 inserts into the Mycobacter-
ium tuberculosis genome in a variety of ways with a variety
of potential effects [38], some of which we have discussed
previously [7]. The DR/CRISPR region is a hot spot for
IS6110 insertions, where there can be 0, 1, or more
IS6110 elements inserted in the DR region [39, 40]. In
this study all the MTBC strains examined had 1 mid DR
IS6110 mobile element (Fig. 2). After CRISPR deletion,
along with deletion of varying amounts of DR-flanking
sequences, the DR region was left with a residual IS6110
mobile element attached to what remained of the flank-
ing sequences (Fig. 2). The IS6110 mobile element has
the ability to delete sequences on either side of it [39]. In
the MTBC Beijing family, the mid DR IS6110 mobile
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element is found in reverse orientation to the H37Rv
mid DR IS6110 sequence [4, 41]. The results shown in
this paper were consistent with these previous findings,
as except for the deleted-DR Beijing strains from patient
B, all Beijing mid DR IS6110 elements from validated
complete chromosome sequences, had orientations
inverse (Table 1, and shown in red in Additional File 6,
Figure S1) to the mid DR H37Rv IS6110 orientation. In
the deleted-DR Beijing strains from patient B, the re-
sidual mid DR IS6110 was oriented in the same direction
as the reference H37Rv mid DR IS6110 mobile element
(Patient B, Additional File 6: Figure S1). We speculate
that generation of the deleted-DR extended RD207
deletion involved this IS6110 mobile element, which in
the process was “flipped” from its previous characteristic
Beijing inverse orientation (presumably generated by for-
mation of the ancestral Beijing-defining RD207 deletion)
back to a wild type H37Rv-like orientation. The mechan-
ism behind the IS6110 ability to generate deletions has
been investigated [39, 41], but to the best of our
knowledge this issue has not been resolved. In summary,
it is probable that the residual IS6110 mobile element
found attached to the presumed (by homology) DR
flanking sequences of the deleted-DR strains (Fig. 2),
played an as yet uncharacterized role in the deletion of
the CRISPR sequences and flanking genes observed to
be deleted in the deleted-DR strains (Fig. 2).
Validation of total loss of CRISPR spacers in deleted-DR
isolates A, B, and C, and in downloaded read-assembled
deleted-DR strain SRR1188186
Approach 1
Recovery of spoligotypes from NGS data for isolates
A, B, and C, and T3_Eth, was accomplished as follows
Table 2 The presence or absence of mutations in CRISPR-associated genes in Mycobacterium tuberculosis complex strains compared
to reference template H37Rv NC_000962.3 4411532 bp. The mutations are listed in ascending order of their location relative to the
reference H37Rv chromosome
Type Gene Location SNP Change Description Rv
deletion cas2 3123625 Beijing RD207 & all deleted-CRISPR strains Rv2816c
deletion cas1 3123967 Beijing RD207 & all deleted-CRISPR strains Rv2817c
SNP cas1 3124014 cga/cgc Ser/S->Ala/A T3_Eth defining Rv2817c
SNP cas1 3124352 gct/gat Ser/S->Ile/I T3_Eth defining Rv2817c
SNP cas1 3124743 cac/caa Val/V->Leu/L proto-Beijing defining Rv2817c
deletion csm6 3124996 Beijing RD207 & deleted-DR A (Haarlem) Rv2818c
SSP csm6 3125070 T3_Eth specific Rv2818c
SSP&SNPs csm6 3125120 proto-Beijing specific Rv2818c
SNP csm6 3125171 gtt/gct Asn/N- > Ser/S ERR212132 specific Rv2818c
SSP csm6 3125690 ERR212132 specific Rv2818c
SNP csm6 3125235 ttg/tta Gln/Q- > stop BCG specific Rv2818c
deletion csm5 3126240 Beijing RD207 Rv2819c
SNP csm5 3126279 atc/att Asp/D- > Asn/N SRR671740 specific Rv2819c
SNP csm5 3127273 gtg/gtt His/H- > Asn/N proto-Beijing defining Rv2819c
SNP csm4 3127466 tcg/gcg Arg/R- > Arg/R BCG specific Rv2820c
SNP csm4 3127717 tgt/tgc Thr/T- > Ala/A T3_Eth defining Rv2820c
truncation csm4 3127930 Beijing RD207 truncation Rv2820c
SNP csm4 3127931 ttt/att Lys/K- > Asn/N Beijing-defining Rv2820c
Nonea csm3 Rv2821c
Nonea csm2 Rv2822c
SNP cas10/csm1 3129359 tcc/tct Gly/G- > Arg/R CDC1551 specific Rv2823c
SNP cas10/csm1 3129675 gcg/gtg Arg/R- > His/H C_0253-12 and C_0309-12 specific Rv2823c
SNP cas10/csm1 3130682 gcc/acc Gly/G- > Gly/G F11 specific Rv2823c
SNP cas10/csm1 3131188 gag/gaa Leu/L- > Phe/F Beijing BT2 specific Rv2823c
SSPs & SNPs cas10/csm1 3131470 Found in all MTBC strains Rv2823c
Nonea cas6 Rv2824c
aNone: no mutations listed for the strains examined; Location: base pair of H37Rv NC_000962.3 where SNP can be found, or base pair approximately in the center
of a given deletion or insertion; SSP short sequence polymorphism, SNP single nucleotide polymorphism
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(by LS, Scripps). A bed file was created using the co-
ordinates of the 43 DR repeat units. This bedfile and
the aligned bam files were used with “samtools bed-
cov” tool to output number of counts for each repeat
unit. In order to produce a binary table matching the
spoligotyping, regions with less than 500 counts were
considered absent. By this method, the correct spoli-
gotypes (spacer complement) could be obtained for
the intact-DR T3_Eth.
Approach 2
In order to validate the total loss of spacers and repeats
in the deleted-DR isolates, for each isolate A, B and C
corrected DRplus sequences (see above: corrected by
substitution of manual PCR-derived contig sequences
spanning the DR region) were examined for spacer and
repeat sequences, which were found to be totally absent
from these corrected DRplus sequences.
Approach 3
In order to further confirm the total loss of CRISPR
spacers in deleted-DR isolates A, B, and C, and in down-
loaded read-assembled deleted-DR strain SRR1188186, a
new application was developed (by PJF, NPHLTA) for
BioNumerics 7.5 and 7.6 and Excel (manuscript in prep-
aration). The application yielded results consistent with
other approaches (1 and 2 above) in that no spacers
were detected in deleted-DR strains, and correct spoligo-
types were assigned to reference H37Rv, reference BCG,
and the 3 sequenced T3_Eth.
CRISPR-Cas defects: comparison of MTBC strains for
insertions/deletions and SNPs in cas genes
Since isolates from patient B were Beijing, it was of
interest that the deleted-DR deletion consisted of a
left-side-of-IS6110 extension (Fig. 2) of the Beijing-
defining RD207 deletion. The RD207 deletion is found in
all modern Beijing [15, 31], and removes most CRISPR-
spacers and cas genes through Rv2820 (csm4) (Fig. 2) [15].
Table 2 lists the cas gene mutations in order of ascending
location on the H37Rv chromosome (although transcrip-
tion is in the reverse direction), and the corresponding
mutated genes for the strains examined in this study
(Table 1). Notable mutations were the extensive deletions
of cas genes in Beijing family members including deletion
of cas1 (Fig. 2); the deletion of cas2 and cas1 by all
deleted-DR strains (Fig. 2); T3_Eth specific missense SNPs
in cas1; and a proto-Beijing specific missense SNP in cas1
(Table 2, Additional file 7: Figures S4–6). T3_Eth is
our largest MDR-containing African-origin cluster,
and has been reported by others to have proclivity for
MDR [42].
How likely is it that the Cas1 proteins from Type III-A
systems in MTBC also have a role in DNA repair in a
manner similar to that of Cas1 proteins from Type I-E
in E. coli?
Babu et al. 2011 [27] induced DNA damage in E. coli by
exposure to mitomycin C, UV light or cisplatin. They
noted, and gave examples, that Cas1 proteins from dif-
ferent genera of bacteria can display related but different
biochemical properties. Thus any given Cas1 protein
must be characterized for its biochemical and functional
roles, which they did for the E. coli Type I-E Cas1, but
which has not yet been done for the MTBC Type III-A
Cas1. Moreover, we and others [43] were not able to find
any studies done in any genus to determine the bio-
chemical and functional roles of Type III systems.
Nevertheless, Makarova et al. 2015 [12] noted that the
Cas1 family is the most conserved Cas protein family
[44, 45] and showed that the Cas1 phylogenetic tree cor-
responds nicely with the phylogeny of the bacterial gen-
era. By use of the NCBI tool CDART [46], we observed
that the E. coli Type I-E Cas1 had homologous domain
architecture with the M. tuberculosis Type III-A Cas1.
The Cas1 proteins from both were members of the Cas1
endonuclease super-family Cas1_I-II-III. Only the E. coli
Cas1 was labeled “multifunctional” because there is no
relevant data yet for M. tuberculosis Cas1, however, we
consider it likely that the MTBC Cas1 will eventually be
shown to have a role in endogenous DNA repair.
It was noted by Makarova et al., 2015, [12] that the
adaptation module (cas1 and cas2) is dispensable in
subtypes III-A and III-B. This would tend to support
the idea that Cas1 in MTBC is nonessential, even if it
does have an endogenous DNA-repair activity role.
Consistent with this, the Beijing family of MTBC has
deleted cas1 and cas2 (Fig. 2), yet still is a very successful
pathogen. However, nonessential does not necessarily
mean non-important. Cas1 is produced in MTBC [30],
except for the possible exceptions noted in our paper
(and any other exceptions yet to be found), and its
absence or mutation-induced defectiveness could in
theory result in impaired DNA repair and consequent
increased mutability.
Has induction of the cas1 gene been observed in
response to DNA-damage in genera other than that of
E. coli which shows Type I-E cas1 induction?
Pyrococcus furiosus has 7 different CRISPR loci and 3
different CRISPR-Cas systems, Type III-B, Type I-G, and
Type I-A [47]. Williams et al., 2007, [48] analyzed the
transcriptome of P. furiosus after induction of DNA
damage by gamma irradiation. They observed 5 genes that
had up to a 10-fold increase in mRNA levels following
gamma irradiation. 3 of the 5 genes were CRISPR-
associated, but none of them was cas1, although 1 was
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predicted to be involved in DNA repair and recombin-
ation [48]. Interestingly, all 3 up-regulated CRISPR-
associated genes belonged to the Type I-A system [47],
and none of the genes in the other 2 systems, Type III-B
and Type I-G, were similarly up-regulated [48]. Williams
et al., 2007, [48] note that some efficient DNA repair
pathways appear to be constitutively expressed in the
hyperthermophilic archaeon P. furiosus, which they
attribute to the result of life at high temperature. To our
knowledge there are no studies of induction of cas1 in
response to DNA-damage, other than the report of
induction of cas1 in E. coli [27].
Life in a macrophage, and frequent exposure to hypoxic
conditions, also lead to a stressful environment for M.
tuberculosis, and we ask if this is the reason that Cas1
was found in vitro in the MTBC proteome by Mawyue-
nyega et al., 2005 [30], that is, is there constitutive ex-
pression of the MTBC Type III-A cas1 gene? Support
for this view comes from findings that cas1 (Rv2817c) is
an essential gene for MTBC growth in vitro [49–51]. In
contrast, for MTBC H37Rv grown in vivo the cas1 gene
was unessential in an infected-mouse model [52] and
the Cas1 protein was not detected in the proteome in an
infected-guinea pig model [53]. Perhaps in vivo expres-
sion of cas genes is regulated differently than in vitro ex-
pression. In any case, if cas1 gene and Cas1 protein are
essential for in vitro growth of MTBC, the deleted-DR
strains and Beijing family strains (all lacking cas1, Fig. 2)
and strains with potentially defective cas1 such as
T3_Eth (Table 2, Additional File 7 Figures S2 and S3),
must have developed compensatory mechanisms which
allowed them to be cultured from clinical samples.
Another possibility that has not been examined, is
whether cas1 expression is somehow connected with pos-
sible constitutive expression of crRNAs – in P. furiosus
the approximately 200 crRNAs from all 7 CRISPR loci are
constitutively expressed (reviewed in Majumdar et al.
2015 [47]), but to our knowledge nothing is known about
the expression of MTBC crRNAs.
What possible effects might the loss of the cas1 gene
have on any given MTBC strain?
Cas1 protein physically and genetically interacts with
key components of E. coli DNA repair systems, includ-
ing recB, recC and ruvB, and cas1 deleted E.coli shows
increased sensitivity to DNA damage and impaired
chromosomal segregation [27]. Is there the possibility of
a similar phenotype in the deleted-DR strains of MTBC,
or intact-DR strains of MTBC, that are defective in the
cas1 gene? There is no data with which to answer this
question, but some pertinent observations can be made
concerning MTBC. As already mentioned, the wide-
spread successful MTBC pathogens of the Beijing family
[54, 55] all lack the cas1 gene as part of their defining
RD207 deletion (Fig. 2, Table 2) [15, 31]. Evidence pre-
sented in this paper showed that all deleted-DR strains
(assigned to Haarlem, Beijing, EAI, and CAS spoligotype
families by RD deletion profiles, Table 1) lost at least
their cas1 and cas2 genes (Fig. 2, Table 2), but previously
Beijing was considered the only natural instance known
of CRISPR-containing bacteria to be without a cas1 gene
[27]. However this knowledge has been updated by
Makarova et al., 2015, [12] who report that the cas1-
cas2 adaptation module is dispensable in Types III-A
and III-B CRISPR-Cas systems. No evidence has been
offered for impaired chromosomal segregation in Beijing
MTBC, but there appears to be an increased sensitivity
to DNA damage as shown by Beijing-specific SNPs
resulting in a potential mutator phenotype (Table 1)
[37], and by the fact that in Israel [1] and worldwide [37,
54, 56–58], MTBC Beijing family strains are observed to
be robustly transmissible (at least in the patient’s country
of origin) and to have an increased tendency to be MDR.
Thus one could speculate that in Beijing, loss of cas1
may have contributed to increased adaptability (caused
by increased mutability due to decreased DNA repair
function resulting from loss of Cas1 and loss of DNA
repair activity from the DNA repair genes/gene products
with which Cas1 interacts [27, 59]). In this regard, it is
notable that the largest MDR-containing African-origin
cluster in Israel [1] and some parts of Africa [42] is
T3_Eth, which was shown in this study to have 2
potentially disruptive SNP missense mutations in its
cas1 gene (Table 2, Additional file 7, Figures S2 and S3).
Further studies are necessary to determine whether
T3_Eth has functional Cas1.
MTBC strains differ from most other bacteria by
lacking a mismatch repair system [60, 61], the lack of
which causes instability within genomic regions contain-
ing nucleotide repeats [61]. We previously published a
possible instance of this instability observed in a large
cluster of CAS family MTBC in Israel [7], and one could
speculate that this instability may be one of the drivers
of MIRU-VNTR polymorphism in general which is
extremely useful in molecular epidemiology of MTBC
[5]. However, Wanner et al. [61] analyzed the MTBC
strain H37Rv and other bacteria, and determined that
deficiency in DNA-repair increases the selection for
inherently stable genomes “by using codons to encode
proteins in a context-dependent manner that prevents
the emergence of nucleotide repeats.” The results
reported and summarized in our paper suggest that
different families of MTBC have different burdens of
DNA-repair deficiency (Table 1, Table 2), and thus the
important observation of stabilization of the H37Rv
genome may not be generalizable to all MTBC without
examining other strains belonging to at least the other
major families of MTBC.
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The effect of defective DNA-repair genes is cumulative:
the more defective DNA-repair genes, the more mutability
[62], which presumably could lead to increased adaptabil-
ity, with consequent accumulation of mutations in global
transcription/stress response genes favoring survivability/
persistence, transmissibility, and acquisition of drug
resistance. All MTBC strains, as noted above, lack the
mismatch repair system, and it is therefore important to
draw attention to the possible cumulative effect in
Beijing set in motion by the additional loss of cas1 (Fig. 2,
Table 2) and its putative associated DNA-repair network
[27], in addition to other known Beijing-specific defect-
ive DNA-repair genes, (Table 1, [37]). The DNA-repair
mechanism in MTBC is already known to be one of the
slowest in bacteria [59], and cumulative loss of DNA-
repair functionality could only be expected to make the
DNA-repair mechanism even slower, exacerbating the
acquisition of mutations known to result from defective
DNA-repair [62].
Conclusions
Deleted-DR strains showed complete loss of clustered
regularly interspaced short palindromic repeats (CRISPR)
and accompanying spacers, retention of the mid-CRISPR
IS6110 mobile element in clonally specific orientation,
and accompanying clonally-specific loss of flanking genes,
including adjacent CRISPR-associated (cas) genes [12]. All
deleted-DR strains were accompanied by a loss of at least
the cas2 and cas1 genes. Tentative MIRU-VNTR-based
assignments of the deleted-DR isolates to MTBC major
spoligotype families A Haarlem, B Beijing, and C EAI were
validated by identifying lineage-defining long sequence
polymorphisms (LSPs) known as region of difference (RD)
deletions [14, 15, 17], corresponding to major spoligotype
families [17]. Similarly, the deleted-DR strain SRR1188186
whose sequence was assembled from downloaded reads,
deleted cas2 and cas1 and was assigned by RD deletion to
the MTBC major spoligotype family CAS. Since cas1 de-
leted E.coli shows increased sensitivity to DNA damage
and impaired chromosomal segregation [27], we discussed
the possibility of a similar phenotype in the deleted-DR
strains of MTBC and in the intact-DR MTBC Beijing that
are defective in the cas1 gene (having deleted it), and in
the intact-DR MTBC T3_Eth that are potentially defective
in the cas1 gene (having 2 potentially disruptive missense
SNPs in it).
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